Cargando…

Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach

Background and Objectives: The virus SARS-CoV2, which causes COVID-19, affects the endocrine system. This study investigated serum concentrations of the thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4) in 53 outpatients infected with SARS-CoV2 and 53 non-infected matched...

Descripción completa

Detalles Bibliográficos
Autores principales: Naghashpour, Mahshid, Darvishi, Ali, Adelipour, Maryam, Bagheri, Reza, Wong, Alexei, Suzuki, Katsuhiko, Golabi, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318863/
https://www.ncbi.nlm.nih.gov/pubmed/35888610
http://dx.doi.org/10.3390/medicina58070891
_version_ 1784755406233403392
author Naghashpour, Mahshid
Darvishi, Ali
Adelipour, Maryam
Bagheri, Reza
Wong, Alexei
Suzuki, Katsuhiko
Golabi, Sahar
author_facet Naghashpour, Mahshid
Darvishi, Ali
Adelipour, Maryam
Bagheri, Reza
Wong, Alexei
Suzuki, Katsuhiko
Golabi, Sahar
author_sort Naghashpour, Mahshid
collection PubMed
description Background and Objectives: The virus SARS-CoV2, which causes COVID-19, affects the endocrine system. This study investigated serum concentrations of the thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4) in 53 outpatients infected with SARS-CoV2 and 53 non-infected matched participants in Khuzestan Province, Iran. We also examined the possible association of clinical symptoms progression and disease severity with serum concentrations of TSH, T3, and T4. Materials and Methods: A checklist was applied to collect demographic and clinical data. Blood samples were taken for biochemical analysis of serum concentrations of TSH, T3, and T4. Clinical symptoms of the infected outpatients were monitored weekly for 28 days. Results: Our results indicated that, as the severity of the disease increased, the respiratory and pulse rates raised significantly. Additionally, disease severity was significantly different between genders. Specifically, 79.5% of the asymptomatic/mild, and 38.5% of moderate outpatients were men. We also found significantly lower serum T3 but higher T4 in infected outpatients, compared with controls. However, serum TSH did not significantly differ between the two groups. The generalized estimating equation (GEE) analysis revealed no relationship between clinical symptoms progression and disease severity with serum concentrations of TSH, T3, and T4 in our study population. Additionally, GEE analysis showed that the odds ratio of neurological symptoms among women was 2.5 times that of men, the odds ratio of neurological symptoms in illiterates was 10 times higher than that of those without a high-school diploma, and the chance of developing pulmonary symptoms in those without high-school diploma was about 21 times higher than illiterates. Conclusion: In conclusion, this study showed that infected outpatients had significantly lower serum T3 but higher T4 than non-infected participants. There was no relation between symptom progression and disease severity with serum concentrations of TSH, T3, and T4, but educational status and sex significantly affected the chance of neurological and pulmonary symptoms occurring over 28 days. Our results may be used to develop potential therapies to treat COVID-19 disease.
format Online
Article
Text
id pubmed-9318863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93188632022-07-27 Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach Naghashpour, Mahshid Darvishi, Ali Adelipour, Maryam Bagheri, Reza Wong, Alexei Suzuki, Katsuhiko Golabi, Sahar Medicina (Kaunas) Article Background and Objectives: The virus SARS-CoV2, which causes COVID-19, affects the endocrine system. This study investigated serum concentrations of the thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4) in 53 outpatients infected with SARS-CoV2 and 53 non-infected matched participants in Khuzestan Province, Iran. We also examined the possible association of clinical symptoms progression and disease severity with serum concentrations of TSH, T3, and T4. Materials and Methods: A checklist was applied to collect demographic and clinical data. Blood samples were taken for biochemical analysis of serum concentrations of TSH, T3, and T4. Clinical symptoms of the infected outpatients were monitored weekly for 28 days. Results: Our results indicated that, as the severity of the disease increased, the respiratory and pulse rates raised significantly. Additionally, disease severity was significantly different between genders. Specifically, 79.5% of the asymptomatic/mild, and 38.5% of moderate outpatients were men. We also found significantly lower serum T3 but higher T4 in infected outpatients, compared with controls. However, serum TSH did not significantly differ between the two groups. The generalized estimating equation (GEE) analysis revealed no relationship between clinical symptoms progression and disease severity with serum concentrations of TSH, T3, and T4 in our study population. Additionally, GEE analysis showed that the odds ratio of neurological symptoms among women was 2.5 times that of men, the odds ratio of neurological symptoms in illiterates was 10 times higher than that of those without a high-school diploma, and the chance of developing pulmonary symptoms in those without high-school diploma was about 21 times higher than illiterates. Conclusion: In conclusion, this study showed that infected outpatients had significantly lower serum T3 but higher T4 than non-infected participants. There was no relation between symptom progression and disease severity with serum concentrations of TSH, T3, and T4, but educational status and sex significantly affected the chance of neurological and pulmonary symptoms occurring over 28 days. Our results may be used to develop potential therapies to treat COVID-19 disease. MDPI 2022-07-02 /pmc/articles/PMC9318863/ /pubmed/35888610 http://dx.doi.org/10.3390/medicina58070891 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Naghashpour, Mahshid
Darvishi, Ali
Adelipour, Maryam
Bagheri, Reza
Wong, Alexei
Suzuki, Katsuhiko
Golabi, Sahar
Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title_full Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title_fullStr Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title_full_unstemmed Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title_short Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
title_sort serum concentrations of thyroid-stimulating hormone, triiodothyronine, and thyroxine in outpatients infected with sars-cov2 in khuzestan province, iran: a disease clinical course approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318863/
https://www.ncbi.nlm.nih.gov/pubmed/35888610
http://dx.doi.org/10.3390/medicina58070891
work_keys_str_mv AT naghashpourmahshid serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT darvishiali serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT adelipourmaryam serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT bagherireza serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT wongalexei serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT suzukikatsuhiko serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach
AT golabisahar serumconcentrationsofthyroidstimulatinghormonetriiodothyronineandthyroxineinoutpatientsinfectedwithsarscov2inkhuzestanprovinceiranadiseaseclinicalcourseapproach